Denali Therapeutics Inc Equity-NMS: DNLI

Healthcare

Biotechnology

Buy/Sell an entire stock
or a fraction.

Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly

Loading, Please wait...

Error in Fetching Data, Please retry later.

No data available.

Previous close :	$15.56
Open :	$15.25
Today's high :	$15.25
Today's low :	$14.56
52W low :	$14.56
52W high :	$33.31
1Y :	-38.06%
5Y :	-38.83%
EPS(TTM): :	-1.06
Shares O/S :	142.54 M
Market cap :	2.13 B

What is the share price of Denali Therapeutics Inc today?

Denali Therapeutics Inc (DNLI) share price as of April 26, 2024, is $14.96. If you are investing from India, you can always check the valuation in the INR before investing.

Can Indian Investors purchase shares of Denali Therapeutics Inc?

Yes, Indian Investors can invest in the Denali Therapeutics Inc (DNLI) Share by opening an international trading account with Angel One.

How can I purchase Denali Therapeutics Inc shares in India?

Purchasing Denali Therapeutics Inc (DNLI) share from India can be done by:

Directly: By opening an international trading account with Angel One. The process would include KYC verification.
The account activation takes a few minutes to a few hours, after which you can start buying Denali Therapeutics Inc (DNLI) by making deposits in US dollars.
Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.

Can I buy Fractional shares of Denali Therapeutics Inc?

Yes, you can purchase fractional shares of Denali Therapeutics Inc (DNLI) or any other US company shares in Angel One for any dollar amount.

What is the market capitalization value of Denali Therapeutics Inc?

The market capitalization of Denali Therapeutics Inc on April 26, 2024, is $2.13 B.

In which sector Denali Therapeutics Inc belongs?

Denali Therapeutics Inc operates in the Healthcare sector, specifically in the Biotechnology industry.

What documents are required to invest in Denali Therapeutics Inc stocks?

In order to invest in Denali Therapeutics Inc (DNLI) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.)

From start to end, the process is digital and can be seamless.

Denali Therapeutics Inc. is a biopharmaceutical company. The Company is focused on developing a portfolio of product candidates engineered to cross the blood-brain barrier (BBB) for neurodegenerative diseases and lysosomal storage disease. The Company has a portfolio of both small molecule and biotherapeutic medicines, comprising seven product candidates in clinical development across seven indications as well as preclinical therapeutic candidates. Its three late-stage development programs include tividenofusp alfa (DNL310) for mucopolysaccharidosis II (MPS II); BIIB122/DNL151 (LRRK2 inhibitor) for Parkinson’s disease; and DNL343 (eIF2B activator) for amyotrophic lateral sclerosis (ALS). SAR443820/DNL788 (RIPK1 inhibitor) is being evaluated in a Phase II study for multiple sclerosis (MS). In addition, it has a Phase I/II study of TAK-594/DNL593 for frontotemporal dementia-granulin (FTD-GRN) and a Phase I/II study of DNL126 for MPS IIIA (Sanfilippo syndrome).